Stoke Therapeutics Cash from Financing (TTM) Analysis

Stoke Therapeutics Inc (STOK)

12.02 +0.33 (+2.82%) USD | NASDAQ | May 03, 16:00

12.00 -0.02 (-0.17%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	53.01M
September 30, 2023	45.71M
June 30, 2023	45.58M
March 31, 2023	48.96M
December 31, 2022	46.41M
September 30, 2022	46.54M
June 30, 2022	46.51M
March 31, 2022	43.24M
December 31, 2021	1.284M
September 30, 2021	107.98M
June 30, 2021	108.25M

Date	Value
March 31, 2021	108.46M
December 31, 2020	108.11M
September 30, 2020	1.432M
June 30, 2020	-0.241M
March 31, 2020	150.03M
December 31, 2019	149.76M
September 30, 2019	239.35M
June 30, 2019	253.73M
March 31, 2019	103.15M
December 31, 2018	115.64M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.241M

Minimum

Jun 2020

253.73M

Maximum

Jun 2019

84.43M

Average

48.96M

Median

Mar 2023

Cash from Financing (TTM) Benchmarks